INJECTION OF AGENTS FOR INFLAMMATION TREATMENT

摘要

FIELD: medicine. ^ SUBSTANCE: invention concerns medicine and concerns treatment of pathological inflammation caused by a multiple sclerosis or Crohn's disease. The antibody or its immunologically active fragment specifically contacting with the integrin alpha-4 is entered for this purpose. Injection is spent once a week or once a month within at least 6 months. ^ EFFECT: maintenance of achievement of high level of saturation of receptors of the alpha-4 integrin throughout all period of treatment that allows weakening a pathological inflammation effectively and for long time. ^ 28 cl, 12 tbl, 3 ex, 11 dwg